DAFTAR PUSTAKA

1. Price S A. dan Wilson L M. Patofisiologi : Konsep Klinis ProsesProses

Penyakit. Jakarta: EGC;2006:1(6)

2. Wendt E. CCR9 antagonism : potential in the treatment of Inflammatory Bowel

Disease: 119–130.2015.

3. Reshetnyak. Concept of the pathogenesis and treatment of cholelithiasis.

World J Hepatol.2010:4(2); 18-34.

4. Pell C et al. Coming of age , becoming obese : a cross- sectional analysis of

obesity among adolescents and young adults in Malaysia. BMC Public

Health.2016;1–10,

5. Stinton L M and Shaffer E A. Epidemiology of Gallbladder Disease :

Cholelithiasis and Cancer.2012:6( 2);172–187.

6. Della C Corte et al. Management of cholelithiasis in Italian children : A

national multicenter study.2008:14( 9);1383–1388.

7. Hung S, Liao K, Lai S, Li C, and Chen W. Risk factors associated with

symptomatic cholelithiasis in Taiwan : a population-based study. BMC

Gastroenterol.2011:11(1); 111.

8. Asperti M et al. The Lowest Prevalence of Cholelithiasis in the Americas - An

Autopsy-based Study. 2013: (9);365–369.

9. Ginting S A. Description Characteristic Risk Factor of The Kolelitiasis Disease

in The Columbia Asia Medan Hospital. Journal Darma Agung 2011;38-45.

10. Purwanti A R. Hubungan Gaya Hidup dengan Kejadian Penyakit Cholelitiasis

di Ruang Rawat Inap RSI Surakarta. Fakultas Ilmu Kesehatan Universitas

Muhammadiyah Surakarta.2015.

11. Deva A R. Gambaran Kasus Kolelitiasis di Bagian Bedah RSUP dr. M Djamil

Padang Tahun 2014-2015. Fakultas Kedokteran Universitas Andalas.2015

12. Amri R A et al. Proporsi Penderita Batu Empedu dengan Status Gizi Obesitas

di Rumah Sakit Umum Pusat Fatmawati pada tahun 2015 – 2016. Fakultas

Kedoktran Universitas Islam Negri Jakarta. 2017.

13. Susilo L et al. Karakteristik Pasien Cholelithiasis di Rumah Sakit Immanuel

Bandung Periode 1 Januari 2012 – 31 Desember 2012. Fakultas Kedokteran

Universitas Kristen Maranatha . 2012.

14. Jethro E S. Hubungan Status Gizi dan Jenis Kelamin dengan Kejadian

Kolelitiasis Pada Pasien Rawat Inap di Bagian Bedah RSUP. Dr. Muhammad

Hoesin Palembang. Fakultas Kedokteran Universitas Sriwijaya.2016

15. RSI Siti Rahmah Padang. Laporan Rekam Medik Tentang Kolelitiasis tahun

2014-2017. Padang: RSI Siti Rahmah Padang;2018

16. Sobbota. Sobotta Atlas Anatomi Manusia. Edisi 21. Jakarta: EEG Penerbit Buku

Kedokteran;2010.

17. Sherwood, Lauralee. Fisiologi Manusia Dari Sel ke Sistem, Edisi VI. Penerbit

Buku Kedokteran EGC. 2011

18. Setiati, S. Buku Ajar Ilmu. Penyakit Dalam Jilid II edisi V. Jakarta: Interna

Publishing;2015.
19. Cetta, Francesco. 2014. Classification, composititon and Structure of Gallstones.

Relevance of these Parameters for Clinical Presentation and Treatment.2014;51-

65

20. A Ansari-moghaddam, A Khorram, and M. Miri-bonjar. The Prevalence and

Risk Factors of Gallstone Among Adults in South-East of Iran. A Population-

Based Study. 2016;8(4);60–67.

21. Acalovschi M. Cholesterol gallstones: From epidemiology to prevention

Postgrad Med J. 2001;77;(221). Available from: PubMed

22. Hebebrand J et al. A Proposal of the European Association for the Study of

Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the

Three Dimensions Etiology , Degree of Adiposity and Health Risk. 2017;(284–

307).

23. Offei. Obesity – A preventable Diesease. Graha Medical Journal. 2005; 39(3).

24. Mitchell, Nia MD, Catenacci, Vicki MD, dkk. Obesity : Overview of An

Epidemic. 34(4):717-732. National Institutes of Health (NIH)2011

25. Sudoyo, Aru W, dkk. 2009. Buku Ajar Ilmu Penyakit Dalam Jilid 1 Edisi V.

Jakarta : EGC

26. Flier J S. Obesity. In: Kasper D L, Braunwald E, Fauci A S, Hauser S L, Longo

D L, Jameson J L. Harrison’s Principles of Internal Medicine 6th ed. McGraw-

Hill. 2007: 422-30.

27. Klass DM, Lauer N, Hay B, Kratzer W, Fuchs M. Arg64 Variant of The Beta3-

Adrenergic Receptor is Associated with Gallstone Formation. Am j

gastroenterol. 2007;102:2482-2487
28. Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Eleated Body Mass Index as a

Causal Risk Factor for Symptomatic Gallstone Disease: Amendelian

Randomization Study. American Association for the Study of Liver Disease.

2013; 58(6):2133-2141.

29. Kharga, Bikram, Sharma, Barun Kumar, et al. Obesity not necessary, Risk of

Symptomatic cholelithiasis Increase as a Function of BMI. 2016. Available

from: PubMed